| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SPATA5L1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | PRPF4B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | TAF13 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | GABPA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | DEPDC7 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | LURAP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CNOT1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | HTATIP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | C1orf35 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | NR4A1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
